Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Lenvatinib-d4 | 2264050-65-7 | 99.6% | 430.88 | 100 MG
Supplier: Medchemexpress LLC HY10981S500UG
Lenvatinib-d4 is a deuterium-labeled version of Lenvatinib. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, demonstrating potent antitumor activities. Stable heavy isotopes like deuterium are incorporated into drug molecules, primarily as tracers for quantitation during drug development. Deuteration can also impact the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer.
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?